Close Menu

NEW YORK – The Belgian Society of Medical Oncology (BSMO) on Thursday announced a study to evaluate the use of genomic profiling and precision oncology for patients with advanced cancer in Belgium.

BSMO will begin the study, dubbed BALLETT, next month. It will enroll 864 patients with advanced metastatic cancer. These patients will be offered comprehensive genomic profiling, and the deidentified data from the study will be added to a newly established national genomic tumor database overseen by Belgium’s Scientific Institute for Public Health, Sciensano.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Apr
23
Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function. 

Apr
27
Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

Apr
28
Sponsored by
Akoya Biosciences

Single-cell omics assays have become essential tools for identifying and characterizing cell types and states of complex tissues. While each single-modality assay reveals distinctive features about the sequenced cells, true multiomics assays are still in the early stage of development. 

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.